Pharmacology, Toxicology and Pharmaceutical Science
Insulin
100%
Antidiabetic Agent
100%
Glucose
100%
Biological Activity
100%
Hormone
100%
Octapeptide
100%
Mouse
66%
Peptide
50%
Gastric Inhibitory Polypeptide
33%
Fat
33%
Peptide Fragment
33%
Non Insulin Dependent Diabetes Mellitus
16%
Incretin
16%
Immunology and Microbiology
Mouse
100%
Biological Activity
100%
Carboxy Terminal Sequence
100%
Cells
50%
Glucose Blood Level
50%
Insulin Release
50%
Insulin Sensitivity
25%
Energy
25%
Dose
25%
Body Weight
25%
Body Fat
25%
Insulin Blood Level
25%
Keyphrases
Biological Activity
100%
Antidiabetic Potential
100%
Xenin-25
100%
Twice Daily
12%
Glucose-dependent Insulinotropic Polypeptide
12%
Blood Glucose
12%
Fragment Peptide
12%
Treatment Regimen
6%
Type 2 Diabetes Mellitus (T2DM)
6%
Insulin Secretion
6%
Insulin
6%
Plasma Insulin
6%
Insulin Sensitivity
6%
Potential Therapeutics
6%
Glucose-stimulated Insulin Secretion
6%
BRIN-BD11 Cells
6%
Energy Intake
6%
Treatment Duration
6%
K Cells
6%
Insulin Release
6%
High-fat Diet Mice
6%
Glucose-lowering Drugs
6%
Glucose-insulin System
6%
Insulinotropic Effects
6%
Exogenous Glucose
6%
Glycemic Excursion
6%
Incretin Hormones
6%
Feeding Behavior
6%
Therapeutic Utility
6%
Antidiabetic Properties
6%
Release Effect
6%
Peptide Concentration
6%
Glucose Challenge
6%
Body Fat
6%
Fat Stores
6%